key: cord-0740975-5j2gps15
authors: Der-Martirosian, Claudia; Steers, W. Neil; Northcraft, Heather; Chu, Karen; Dobalian, Aram
title: Vaccinating Veterans for COVID-19 at the U.S. Department of Veterans Affairs
date: 2022-02-01
journal: Am J Prev Med
DOI: 10.1016/j.amepre.2021.12.016
sha: e4edc0569b92a819af035a322a39e9e9abb71912
doc_id: 740975
cord_uid: 5j2gps15

Introduction: With the coronavirus disease 2019 (COVID-19) (most recent) Omicron variant surge across the U.S, more research is needed to better understand how vaccination and booster uptake can be increased. COVID-19 vaccinations have proven to help decrease the likelihood of becoming seriously ill, hospitalized, or dying. Studies examining patient characteristics of individuals who received COVID-19 vaccinations are limited. This study examines the patient characteristics of Veterans who were vaccinated during the first 8 months (December 2020–July 2021) of the vaccination rollout at the U.S. Department of Veterans Affairs (VA). Methods: Using VA administrative and clinical data, bivariate and multivariate analyses were conducted to determine sociodemographic and health factors associated with the likelihood of receiving COVID-19 vaccination at the VA. Results: The analytic sample included 5,914,741 VA-users (49.7% vaccinated). Among the VA medical facilities nationwide, COVID-19 vaccination rates (≥1 dose) varied from 33.9% to 73.7%. Veterans who were non-Hispanic American Indian/Alaskan-Natives, younger, living in rural areas, male and unmarried, with VA health insurance only, with fewer chronic conditions, who did not receive the seasonal influenza vaccine, and not living in community living centers or nursing homes were less likely to get vaccinated. Conclusions: Understanding which groups of Veterans are less likely to be vaccinated allows the VA to develop targeted interventions to improve uptake in these groups. These results can also guide non-VA organizations to create evidence-based educational outreach programs that reduce vaccine hesitancy among Veterans that do not use VA.

As of January 24, 2022, a total 87.4% of the U.S. adult population (aged ≥18 years) has received at ≥1 dose of a coronavirus disease 2019 (COVID-19) vaccine and 73.8% are fully vaccinated according to the U.S. Centers for Disease Control and Prevention. 1 Numerous studies have examined COVID-19 vaccine hesitancy or determinants of COVID-19 vaccine uptake in the U.S. [2] [3] [4] [5] [6] [7] [8] [9] In a recent study of 1,971 respondents consisting of a nonprobability convenience sample of U.S. adults, 3 healthcare attitudes, practices, political affiliation, and certain demographic characteristics including age, gender, and race/ethnicity, were associated with willingness to be vaccinated for COVID-19. Another study by Painter et al. 4 examined the demographic characteristics of those who were vaccinated in the U.S. during the first month of the COVID-19 vaccination program (December 14, 2020 through January 14, 2021) . This study found that almost 13 million received ≥1 dose of a COVID-19 vaccine in the U.S. during this period.

Among the 12,928,749 vaccinated, 63% were women, 55% were aged ≥50 years, 16 .8% were aged 40-49 years, and 28.2% were aged 18-39 years. However, it is important to point out that the referenced study focused on the first month of vaccination when targeted vaccination limited access for younger people unless they had immunocompromising conditions or had certain occupations. Data on race/ethnicity were reported for about half (51.9%) of the vaccine recipients (6, 706, 697) , and among those, 60.4% were White and 39.6% were members of racial or ethnic minority groups. Even though there are some states or counties that do track some characteristics of those who get vaccinated, oftentimes these data are incomplete and only bivariate associations are reported. No follow-up studies have examined the demographic characteristics of individuals vaccinated during the >8 months since the COVID-19 vaccination program in the U.S. started. In another study by the Kaiser Family Foundation, 5 14% of the vaccine-eligible Americans consistently refused to get vaccinated since the vaccination rollout in December 2020. The same study also illustrated that some of the correlates of not getting vaccinated are lower education, Republican party affiliation, being White, having lower income (<$40,000), and being insured. For most of the unvaccinated, many believe that vaccination poses a bigger risk than COVID-19 infection. 5 The U.S. Department of Veterans Affairs (VA) began its COVID-19 vaccination program for all Veterans that use VA for their health care (VA-users) in mid-December 2020. 10 BioNTech, or Janssen COVID-19 vaccine) between December 1, 2020 and July 31, 2021. VAusers tend to be more racially diverse, socioeconomically disadvantaged, and medically more complex 13 than the general adult population. As such, understanding patient characteristics of VA-users that are associated with vaccination status is useful not just for VA to identify unvaccinated patients, but may also help public health officials and others identify other unvaccinated patient subpopulations for targeted interventions to reduce vaccine hesitancy.

Using national VA administrative and clinical data, the distribution of vaccination rates at 129 VA Medical Centers nationwide was examined. The initial study population included all Veterans who had accessed the VA healthcare system nationwide during the approved study timeframe (March 1, 2018 to July 31, 2021). This included anyone in the outpatient, inpatient, or fee-based community care databases during the approved study timeframe. All Veterans who accessed care at the VA facilities for vaccination were captured in the outpatient encounter database, including those who may have used the VA for vaccination purposes only. American, non-Hispanic Asian, non-Hispanic American Indian/Alaska Native, non-Hispanic Native Hawaiian/Other Pacific Islander, non-Hispanic multiple races, and unknown); non-VA health insurance status (yes/no); VA priority-based enrollment system, categorized into 4 groups based on service-connected disability rating, income, recent military service, and other factors 14 (no disability, low/moderate disability, high disability, low income); influenza vaccine receipt during the prior influenza season (2019-2020, yes/no; as the prior influenza season is more representative of a typical influenza vaccination uptake than during the COVID-19 pandemic because of lockdowns and corresponding unusually low rates of influenza in 2020-2021); urban/rural residence (urban, rural, highly rural); Charlson Comorbidity Index (a validated and readily applicable risk adjusted summary measure of comorbid diseases), 15 which was categorized into 3 groups: 0=no chronic condition, 1=1 chronic condition, 2= ≥2 chronic conditions; Community Living Center /Nursing Home status (yes/no); 4 age categories (18-44, 45-64, 65-74, ≥75 years); sex (male, female); and marital status (married, not married).

Simple bivariate tests of the differences were conducted between vaccination groups on the listed predictor variables, and multivariate analyses testing the associations of sociodemographic and health factors with the likelihood of receiving ≥1 dose of 1 of the 3 COVID-19 vaccines. For the bivariate analyses, chi-square tests for categorical variables and t-tests for continuous variables were conducted. Multivariate associations of key demographic and clinical variables with vaccination were tested with logistic regression. The model specification included all aforementioned predictor variables and a sex X marital status interaction term, which was hypothesized. The associations of each variable with vaccination are expressed as differences in the adjusted percentages of patients vaccinated between each category and a reference category.

The analysis accounted for clustering at the facility level. Statistical significance was set at p<0.05. All analyses were conducted in Stata, version 15. The study was approved by the local VA IRB. Figure 1 shows that all VA Medical Centers (n=129) had ≥33.9% COVID-19 vaccination rates (≥1 dose). The median vaccination rate was 52.8%, with a maximum percentage of 73.7%, lower quartile of 45.8%, and upper quartile of 59.5%. Figure 2 displays the average COVID-19 vaccination rates by the 5 major districts. The results of the logistic regression analysis are summarized in Table 2 . There is evidence of adjusted associations for each demographic and health variable with vaccination. Most non-White racial/ethnic groups had a higher percentage of individuals who were vaccinated for COVID-19 than non-Hispanic Whites, except for American Indian/Alaskan Natives, whose vaccination percentage was 3.1 points lower than non-Hispanic Whites ( Table 2) . Vaccination among those who have non-VA health insurance was significantly higher than among Veterans with only VA insurance. Similarly, vaccination among those receiving influenza vaccines was dramatically higher than among those not receiving them. Regarding age, vaccination percentages among Veterans aged ≥75 years were higher than those among younger Veterans. In addition, Veterans living in rural or highly rural areas were less likely to be vaccinated than Veterans living in urban areas, and Veterans with single or multiple chronic conditions were more likely to be vaccinated than Veterans with no chronic conditions. For the VA priority-based enrollment items, vaccination rates among those in the high disability group or in the low/moderate disability group were higher than the no disability group. However, the vaccination rate in the low-income group was lower than the no disability group. Furthermore, results of the test of the sex X marital status interaction indicated that female married Veterans were more likely to be vaccinated than male married Veterans, but a much smaller sex difference was observed among unmarried Veterans. Finally, the vaccination rate among Veterans living in community living centers/nursing homes was higher than among Veterans not living in these facilities ( Table 2) .

To date, numerous studies have examined the demographic characteristics associated with COVID-19 vaccine uptake in the U.S. Moreover, this study identified the demographic characteristics of vaccinated Veterans during the past 8 months, a notably longer period than extant studies such as Painter and colleagues. 4 This extended timeframe provides a better understanding of the factors that are more likely to be associated with vaccination uptake over time. Moreover, compared with the general adult population, VA-users are more likely to be members of racial or ethnic minority groups, be less educated, have lower incomes, and have poor health status. 16 Thus, this study provides an examination of groups that are at heightened risk for increased morbidity and mortality from COVID-19.

Using VA administrative and clinical data, this study examined patient factors associated with COVID-19 vaccination uptake during the first 8 months of the vaccination program through July 31, 2021. After adjusting for other predictors, compared with non-Hispanic Whites, the likelihood of being vaccinated was higher among non-Hispanic African Americans, Hispanics, Asians, Native Hawaiians or Other Pacific Islanders, but not American Indian/Alaskan Natives.

These findings might reflect the VA's increased outreach efforts to racial/ethnic minorities, or differences in political affiliation across differing racial and ethnic groups. These study findings support the Kaiser Family Foundation study results, which also indicated that Whites were more likely to be unvaccinated. The study results also illustrated that the low-income Veterans were less likely to get vaccinated, which also support the Kaiser Family Foundation study results, where low income was associated with being unvaccinated. The oldest age group (≥75 years), which is most at risk for morbidity and mortality from COVID-19 and was prioritized for the initial rollout of the vaccine, had the highest vaccination rate. Veterans living in rural or highly rural areas were less likely to get vaccinated than those in urban areas, perhaps because of limited access to the main VA medical facilities in urban areas, which were the primary locations for vaccine distribution. Female compared with male Veterans, especially married female Veterans compared with married male Veterans, Veterans with non-VA insurance coverage compared with Veterans with VA-only insurance, and Veterans with single or multiple chronic conditions compared with Veterans with no chronic conditions, were all more likely to get vaccinated for COVID-19.

This study has limitations. First, the data are based on electronic healthcare records, which have limited sociodemographic information and lack data on behavioral and attitudinal factors that might be associated with vaccination uptake. Moreover, some VA-users might have been vaccinated outside of the VA and may show up in the data as unvaccinated; it is unclear whether this misclassification might be random or systematic and how it might impact the study results. It should be noted that VA clinicians should inquire about vaccine status during appointments and thus at least some individuals who were vaccinated outside VA were included. However, given the recency of the pandemic and the availability of COVID-19 vaccines, probability-based, national survey studies of COVID-19 vaccine hesitancy that include many of the measures that were examined in this study are nonexistent. Conducting secondary data analyses using administrative and clinical data from the VA, which is the largest integrated healthcare system in the U.S., provides information about factors that might be associated with vaccination uptake.

Second, as the COVID-19 vaccination program is ongoing, future studies beyond the initial 8month rollout could lead to somewhat different findings. Third, the generalizability and applicability of the study findings to non-Veterans or to the 10 million Veterans that do not receive care from VA may be limited. However, non-VA healthcare organizations can still learn lessons from these findings. VA has made significant efforts to reach out to its patients, including efforts to encourage VA healthcare providers to discuss vaccination during patient visits. Lastly, it is important to note that limiting the analytic sample to those with complete data on all study variables may have reduced the generalizability of the findings as well. Given this knowledge gap and the recency of the COVID-19 vaccines, this study helps bridge the gap by conducting secondary analysis of VA administrative and clinical data to identify the most salient sociodemographic and health risk factors associated with COVID-19 vaccination uptake.

A better understanding of the socioeconomic and health risk determinants of vaccination among Veterans can help guide the VA in efforts to increase COVID-19 vaccination rates among younger Veterans, male Veterans, Whites, the uninsured (non-VA), and Veterans living in rural/highly rural areas. These findings could also assist non-VA healthcare organizations, safety net community clinics, public health departments, and others to create evidence-based educational outreach programs and other interventions to help socioeconomically disadvantaged, racially diverse, and medically vulnerable patient populations increase vaccine uptake. In coming months, additional research will be needed to understand the characteristics of those who are and are not getting vaccinated and reasons for their hesitancy or acceptance. Moreover, as boosters are rolled out and should future annual immunization for COVID-19 be required, additional studies will be required to examine which groups are likely to uptake the vaccine on an ongoing basis. 

COVID-19 Vaccinations in the United States

Determinants of COVID-19 vaccine hesitancy: evident from a choice-based conjoint experiment. Centers for Open Science

Factors associated with US adults' likelihood of accepted COVID-19 vaccination

Demographic characteristics of persons vaccinated during the first month of the COVID-19 vaccination program -United States

Unvaccinated America, in 5 charts. FiveThirtyEight

The nature and extent of COVID-19 vaccination hesitancy in healthcare workers

COVID-19 Vaccination hesitancy in the United States: a rapid national assessment

Attitudes and Intentions of US Veterans Regarding COVID-19 Vaccination

Vaccine hesitancy as an opportunity for engagement: A rapid qualitative study of patients and employees in the U.S. Veterans Affairs healthcare system

VA announces initial plans for COVID-19 vaccine distribution. U.S. Department of Veterans Affairs

All veterans, their spouses and caregivers eligible to get COVID vaccine through VA under newly-passed bill. Military Times

Learning from the past to improve VA healthcare

Main results report, prepared for Strategic Analysis Service (SAS) Office of Strategic Planning and Analysis (OSPA) Veterans Health Administration

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Are patients at Veterans Affairs Medical Centers sicker? A comparative analysis of health status and medical resource use

LIST OF FIGURES >75 1

American Indian or Alaskan Native 39,970 (0.7) 17,099 (42.8) Non-Hispanic Asian

Non-Hispanic Native Hawaiian or Other Pacific Islander

authors read and approved the final manuscript. The materials in this article have not been presented elsewhere. No financial disclosures were reported by the authors of this paper.

Adjusted % COVID vaccinated